Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model

por Prioli, Katherine M., Karp, Julie Katz, Lyons, Nina M., Chrebtow, Vera, Herman, Jay H., Pizzi, Laura T.
Publicado 2018

Cost implications of implementation of pathogen-inactivated platelets

por McCullough, Jeffrey, Goldfinger, Dennis, Gorlin, Jed, Riley, William J, Sandhu, Harpreet, Stowell, Christopher, Ward, Dawn, Clay, Mary, Pulkrabek, Shelley, Chrebtow, Vera, Stassinopoulos, Adonis
Publicado 2015